Latest filing published 03 Dec 2025 for Sonnet BioTherapeutics Holdings, Inc..
Insider track record
Donald J. Griffith: trading record in brief
Filings by Donald J. Griffith span 2 companies, the busiest being Sonnet BioTherapeutics Holdings, Inc. and Outlook Therapeutics, Inc. Between 9 November 2016 and 2 December 2025, the trades on record add up to 13 filings.
The open-market record consists of 1 sale worth €4, with no purchase. Outside the open market, there are 9 share grants and 1 option exercise.
Most recently, on 3 December 2025, the filings show a transaction in Sonnet BioTherapeutics Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Donald J. Griffith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,375 sharesCommon StockSEC:0001493152-25-026063:0
- 10,000 sharesCommon StockSEC:0001641172-25-019780:0
- 317 sharesCommon StockSEC:0001493152-24-048954:0
- 497 shares@ US$1.046.6% of flowCommon StockSEC:0001493152-23-005461:1
- 3,214 sharesCommon StockSEC:0001493152-23-005461:0
- 4,507 shares@ US$0.367321.1% of flowCommon StockSEC:0001493152-22-009480:1
- 15,000 sharesCommon StockSEC:0001493152-22-009480:0
- 4,235 shares@ US$1.51100.0% of flowCommon StockSEC:0001493152-21-013204:0
- 20,000 shares0Common StockSEC:0001493152-20-012571:0
- 79,928 sharesCommon StockSEC:0001493152-20-005842:0
- 1 shares@ US$3.75100.0% of flowCommon StockSEC:0001214659-16-015013:0
- 144,927 shares0Restricted Stock UnitsSEC:0001214659-16-014640:0
- 144,927 sharesCommon StockSEC:0001214659-16-014640:1
13 of 13 declarations